Abstract
Dipeptidyl peptidase (DPP)-4 inhibitors inhibit the activity of the enzyme responsible for the initial rapid degradation of the incretin hormones, thereby enhancing their antihyperglycemic effects.
| Original language | English |
|---|---|
| Title of host publication | Handbook of incretin therapies in type 2 diabetes |
| Editors | S Gough |
| Place of Publication | Switzerland |
| Publisher | Springer |
| Publication date | 2016 |
| Pages | 45-60 |
| Chapter | 4 |
| ISBN (Print) | 978-3-319-08981-2 |
| ISBN (Electronic) | 978-3-319-08982-9 |
| DOIs | |
| Publication status | Published - 2016 |